ArticleAmerican journal of respiratory and critical care medicine2023
Incidence and Progression of Fibrotic Lung Disease in an At-Risk Cohort.
Open access · greenAbstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
5.8field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 41 citations in OpenAlex.
- Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement.American journal of respiratory and critical care medicine · 2025Guideline
- A systematic review of the role of quantitative CT in the prognostication and disease monitoring of interstitial lung disease.European respiratory review : an official journal of the European Respiratory Society · 2025Pooled it
- Prevalence, Risk Factors, and Outcomes of Adult Interstitial Lung Abnormalities: A Systematic Review and Meta-Analysis.American journal of respiratory and critical care medicine · 2023Pooled it
- Alveolar niche disruption and aberrant epithelial reprogramming are early hallmarks of idiopathic pulmonary fibrosis.bioRxiv : the preprint server for biology · 2026Article
- Familial interstitial lung disease: emerging insights into screening and genetic risk.Frontiers in medicine · 2026Review
- Interstitial lung abnormalities: to treat or not to treat? The hamlet dilemma.Frontiers in medicine · 2026Review
- Genetic Familial Interstitial Lung Disease.Clinics in chest medicine · 2025Review
- How Low Can You Go: Exploring the Role of Low-Dose Computed Tomography in Interstitial Lung Disease Detection.Annals of the American Thoracic Society · 2025Article
- Protein biomarkers of interstitial lung abnormalities in relatives of patients with pulmonary fibrosis.The European respiratory journal · 2025Article
- A Comprehensive Review of Interstitial Lung Abnormalities.Respirology (Carlton, Vic.) · 2025Review
- Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study.American journal of respiratory and critical care medicine · 2024Article
- Big Things Have Small Beginnings: Clinical Implications of Early Interstitial Lung Disease.American journal of respiratory and critical care medicine · 2024Article
- Impact of the COVID-19 Pandemic on a Program to Screen for Subclinical Familial Pulmonary Fibrosis.American journal of respiratory and critical care medicine · 2024Article
- Bystander No More: Small Airway Involvement in Idiopathic Pulmonary Fibrosis.American journal of respiratory and critical care medicine · 2024Article
- Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.American journal of respiratory and critical care medicine · 2024Review
- Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report.American journal of respiratory and critical care medicine · 2024Article
- Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis.Annals of the American Thoracic Society · 2023Article
- Detection of Pulmonary Fibrosis with a Collagen-Mimetic Peptide.ACS sensors · 2023Article
- Transitional cell states sculpt tissue topology during lung regeneration.Cell stem cell · 2023Article
- The Promise of Quantitative Computed Tomographic Analysis in Assessing Progression of Interstitial Lung Abnormalities and Emphysema in Smokers.American journal of respiratory and critical care medicine · 2023Article
Corrections and comments
- Commented on by
Authors and funding
23 authors at 6 institutions in 2 countries.
Mark P SteeleDepartment of Medicine.
Anna L PeljtoDepartment of Medicine.ORCID 0000-0002-8389-0736
Susan K MathaiCenter for Advanced Heart and Lung Disease, Baylor University Medical Center at Dallas, Dallas, Texas.
Stephen HumphriesDepartment of Radiology.ORCID 0000-0002-5113-4530
Tami J BangDepartment of Radiology, and.
Andrea OhDepartment of Radiology.
Shawn TeagueDepartment of Radiology.
Giuseppe CicchettiDepartment of Diagnostic Imaging, Oncological Radiotherapy, and Hematology, Fondazione Policlinico University Gemelli, Rome, Italy.
Christopher SigakisDepartment of Regional Radiology, Cleveland Clinic Imaging Institute, Cleveland, Ohio; and.
Jonathan A KropskiDepartment of Medicine, Vanderbilt University, Nashville, Tennessee.
James E LoydDepartment of Medicine, Vanderbilt University, Nashville, Tennessee.
Timothy S BlackwellDepartment of Medicine, Vanderbilt University, Nashville, Tennessee.ORCID 0000-0002-0337-7052
Kevin K BrownDepartment of Medicine, and.
Marvin I SchwarzDepartment of Medicine.
Rachel A WarrenDepartment of Medicine.
Julia PowersDepartment of Medicine.
Avram D WaltsDepartment of Medicine.
Cheryl MarkinDepartment of Medicine, Vanderbilt University, Nashville, Tennessee.
Tasha E FingerlinCenter for Genes, Environment, and Health, National Jewish Health, Denver, Colorado.
Ivana V YangDepartment of Medicine.
David A LynchDepartment of Radiology.
Joyce S LeeDepartment of Medicine.
David A SchwartzDepartment of Medicine.ORCID 0000-0001-6743-8443
Vanderbilt University · USAgostino Gemelli University Polyclinic · ITBaylor University Medical Center · USCleveland Clinic · USNational Jewish Health · USUniversity of Colorado Denver · US
Funding
Mechanisms of Familial Pulmonary FibrosisP01HL092870 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLACKWELL, TIMOTHY S. · 2010 to 2020
$21.6MTargeting early events in MUC5B-driven lung injury and fibrosisP01HL162607 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI David Albert Schwartz · 2023 to 2026
$12.4MMUC5B, a novel therapeutic target for Idiopathic Pulmonary Fibrosis (IPF)UH3HL123442 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SCHWARTZ, DAVID ALBERT · 2016 to 2018
$4.8MPreclinical Pulmonary Fibrosis, an opportune rare disease cohortUH3HL151865 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SCHWARTZ, DAVID ALBERT · 2022 to 2025
$4.3MMolecular Determinants of Usual Interstitial Pneumonia (UIP)R01HL158668 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI David Albert Schwartz, Ivana V Yang · 2022 to 2026
$3.5MMUC5B, a novel therapeutic target for Idiopathic Pulmonary Fibrosis (IPF)UH2HL123442 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SCHWARTZ, DAVID ALBERT · 2014 to 2015
$3.0MGenes and Transcripts that Interact with MUC5B in Pulmonary FibrosisR01HL149836 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI CLOUTHIER, DAVID E., SCHWARTZ, DAVID ALBERT · 2020 to 2023
$3.0MPreclinical Pulmonary Fibrosis, an opportune rare disease cohortUG3HL151865 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SCHWARTZ, DAVID ALBERT · 2020 to 2021
$1.7MlncRNAs, Linking Genetic Susceptibility to Molecular Phenotype in IPFI01BX005295 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI David Albert Schwartz · 2022 to 2026
–BLRD VA I01 BX002378BLRD VA I01 BX005295NHLBI NIH HHS P01 HL092870NHLBI NIH HHS P01 HL162607NHLBI NIH HHS PO1-HL0928701NHLBI NIH HHS R01 HL149836NHLBI NIH HHS R01 HL158668NHLBI NIH HHS RO1-HL149836NHLBI NIH HHS UG3 HL151865NHLBI NIH HHS UG3-HL151865NHLBI NIH HHS UH2/3-HL151865NHLBI NIH HHS UH2 HL123442NHLBI NIH HHS UH3 HL123442NHLBI NIH HHS UH3 HL151865
Abstract
PubMed holds no abstract for this paper.
Indexed as
Idiopathic Pulmonary FibrosisLung Diseases, InterstitialCohort StudiesDyspneaHumansIncidenceLungRetrospective Studiesfamilial idiopathic pulmonary fibrosisidiopathic pulmonary fibrosispulmonary fibrosis
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.